MARKET

NVIV

NVIV

Invivo Therapeut
NASDAQ
4.220
-0.030
-0.71%
Opening 11:32 09/30 EDT
OPEN
4.380
PREV CLOSE
4.250
HIGH
4.380
LOW
4.220
VOLUME
599
TURNOVER
2.41K
52 WEEK HIGH
17.71
52 WEEK LOW
3.500
MARKET CAP
5.87M
P/E (TTM)
-0.5399
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Benzinga · 3d ago
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
Benzinga · 3d ago
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference
CAMBRIDGE, Mass., September 09, 2022--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D.,...
Business Wire · 09/09 12:00
CinCor, Karuna top healthcare gainers; Reata, uniQure lead losers' pack
Gainers: CinCor Pharma CINC +66%. Karuna Therapeutics KRTX +61%. 23andMe (<a href="https://seekingalpha.com/symbol/ME?utm_medium=referral&utm_source=webull.com" title="23andMe Ho...
Seekingalpha · 08/08 14:04
BioNTech, Palantir Technologies, AMTD IDEA among premarket losers' pack
NuZee (NUZE) -24% on <a href="https://seekingalpha.com/news/3868554-nuzee-stock-gains-...
Seekingalpha · 08/08 12:36
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investor Place · 08/08 11:29
What Is Going on With InVivo Therapeutics (NVIV) Stock Today?
Investor Place · 08/04 16:33
InVivo, ChemoCentryx top healthcare gainers; Helius, Enveric lead losers' pack
Gainers: InVivo Therapeutics (NVIV) +114%. Che...
Seekingalpha · 08/04 14:04
More
About NVIV
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.

Webull offers kinds of Invivo Therapeutics Holdings Corp stock information, including NASDAQ:NVIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVIV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NVIV stock methods without spending real money on the virtual paper trading platform.